Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, but it requires buy-in from policy makers, biopharmaceutical firms ...

Value assessment of new drugs and devices is gaining importance in the U.S. health care system. Pressure to do it right is accelerating.

The COVID-19 pandemic has made clear the critical need for reliable information that patients and those who care for them can use to navigate a complex health care landscape. The Patient-Centered ...